Article references

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes

Ting Wang, Huiquan Yin, Yan Li, Lingxiao Zhao, Xiahui Sun, Hua Cong

Parasite, 24 (2017) 12

Published online: 2017-04-03

DOI: https://doi.org/10.1051/parasite/2017013

This article has been cited by the following article(s):

Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against Toxoplasma gondii

Carina Brito, Camila Lourenço, Joana Magalhães, Salette Reis and Margarida Borges
Vaccines 11 (4) 733 (2023)
https://doi.org/10.3390/vaccines11040733

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections

Cal Koger-Pease, Dilhan J. Perera and Momar Ndao
Pharmaceuticals 16 (3) 334 (2023)
https://doi.org/10.3390/ph16030334

Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection

Doaa E. Said, Eglal I. Amer, Eman Sheta, Shaimaa Makled, Hala E. Diab and Fadwa M. Arafa
Tropical Medicine and Infectious Disease 7 (12) 401 (2022)
https://doi.org/10.3390/tropicalmed7120401

Histone deacetylase SIR2 in Toxoplasma gondii modulates functions of murine macrophages in vitro and protects mice against acute toxoplasmosis in vivo

ZhengQing Yu, SiYing Chen, MuhammadTahir Aleem, et al.
Microbial Pathogenesis 154 104835 (2021)
https://doi.org/10.1016/j.micpath.2021.104835

Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant

Zhengqing Yu, Wenxi Ding, Muhammad Tahir Aleem, Junzhi Su, Junlong Liu, Jianxun Luo, Ruofeng Yan, Lixin Xu, Xiaokai Song and Xiangrui Li
Pharmaceutics 13 (5) 752 (2021)
https://doi.org/10.3390/pharmaceutics13050752

Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development

Ki-Back Chu and Fu-Shi Quan
Vaccines 9 (5) 413 (2021)
https://doi.org/10.3390/vaccines9050413

Recombinant Toxoplasma gondii Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo

Zhengqing Yu, Yujia Lu, Zhaoyi Liu, Muhammad Tahir Aleem, Junlong Liu, Jianxun Luo, Ruofeng Yan, Lixin Xu, Xiaokai Song and Xiangrui Li
Vaccines 9 (4) 357 (2021)
https://doi.org/10.3390/vaccines9040357

Structural predication and antigenic analysis of ROP16 protein utilizing immunoinformatics methods in order to identification of a vaccine against Toxoplasma gondii: An in silico approach

Ali Dalir Ghaffari, Abdolhossein Dalimi, Fatemeh Ghaffarifar and Majid Pirestani
Microbial Pathogenesis 142 104079 (2020)
https://doi.org/10.1016/j.micpath.2020.104079

Mucosal Vaccines

Hirotomo Kato
Mucosal Vaccines 841 (2020)
https://doi.org/10.1016/B978-0-12-811924-2.00050-X

Systematic review and meta-analysis of variation in Toxoplasma gondii cyst burden in the murine model

Gabrielle F. Watson and Paul H. Davis
Experimental Parasitology 196 55 (2019)
https://doi.org/10.1016/j.exppara.2018.12.003

Muscle Gene Therapy

Axel Rossi and Hildegard Büning
Muscle Gene Therapy 645 (2019)
https://doi.org/10.1007/978-3-030-03095-7_36

Rhoptry antigens asToxoplasma gondiivaccine target

Masoud Foroutan, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhosein Dalimi and Ogholniaz Jorjani
Clinical and Experimental Vaccine Research 8 (1) 4 (2019)
https://doi.org/10.7774/cevr.2019.8.1.4

Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice

Dongchao Zhang, Ning Jiang and Qijun Chen
Vaccine 37 (8) 1118 (2019)
https://doi.org/10.1016/j.vaccine.2018.12.044

Vaccination challenges and strategies against long-lived Toxoplasma gondii

Fei-Kean Loh, Sheila Nathan, Sek-Chuen Chow and Chee-Mun Fang
Vaccine 37 (30) 3989 (2019)
https://doi.org/10.1016/j.vaccine.2019.05.083

Vaccination against Toxoplasma gondii using rhoptry antigens: a systematic review

Roghiyeh Faridnia, Ahmad Daryani, Shahabeddin Sarvi, Mehdi Sharif and Hamed Kalani
Comparative Immunology, Microbiology and Infectious Diseases 59 32 (2018)
https://doi.org/10.1016/j.cimid.2018.09.005

Routing dependent immune responses after experimental R848-adjuvated vaccination

Susan van Aalst, Manon A.A. Jansen, Irene S. Ludwig, et al.
Vaccine 36 (11) 1405 (2018)
https://doi.org/10.1016/j.vaccine.2018.01.077

Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii

Masoud Foroutan, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhosein Dalimi and Majid Pirestani
Infection, Genetics and Evolution 62 193 (2018)
https://doi.org/10.1016/j.meegid.2018.04.033

Recent progress in microneme-based vaccines development againstToxoplasma gondii

Masoud Foroutan, Leila Zaki and Fatemeh Ghaffarifar
Clinical and Experimental Vaccine Research 7 (2) 93 (2018)
https://doi.org/10.7774/cevr.2018.7.2.93

Immune responses and protection after DNA vaccination againstToxoplasma gondiicalcium-dependent protein kinase 2 (TgCDPK2)

Kai Chen, Jin-Lei Wang, Si-Yang Huang, et al.
Parasite 24 41 (2017)
https://doi.org/10.1051/parasite/2017045